EUVIMEDEUVIMED entdecken
Crossref

Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells

Chun-Yu Fu, Pen-An Liao, Tzu-Hsiang Lin, Fei-Ting Hsu, Dai-Cheng Dong, Wei-Ting Chen

Anticancer Research · 2024

DOI: 10.21873/anticanres.17360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Chun-Yu Fu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Imipramine, ErbB Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsImipramineErbB ReceptorsApoptosisSignal TransductionHumansCell Line, TumorNeoplasm InvasivenessMAP Kinase Signaling SystemCell ProliferationCell Movement

Stichwörter der Autor:innen

Hepatocellular carcinomaepidermal growth factor receptor (EGFR)imipraminemetastasis

Substanzen

ImipramineErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Department of Colon and Rectal Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
  • School of Medicine, National Tsing Hua University, Hsinchu, Taiwan, R.O.C.
  • Department of Radiology, Cathay General Hospital, Taipei, Taiwan, R.O.C.
  • Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, R.O.C.
  • Department of Psychiatry, Zuoying Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C.; wt820368@yahoo.com.tw.

Zitieren

APA

Fu, C. Y., Liao, P. A., Lin, T. H., Hsu, F. T., Dong, D. C., & Chen, W. T. (2024). Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17360

Vancouver

Fu CY, Liao PA, Lin TH, Hsu FT, Dong DC, Chen WT. Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells. Anticancer Research. 2024. doi:10.21873/anticanres.17360

BibTeX
@article{Fu2024,
  author = {Fu, Chun-Yu and Liao, Pen-An and Lin, Tzu-Hsiang and Hsu, Fei-Ting and Dong, Dai-Cheng and Chen, Wei-Ting},
  title = {Imipramine-mediated Suppression of EGFR Signaling Attenuates Invasive and Progressive Abilities of Hepatocellular Carcinoma Cells},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17360}
}
Kostenlos starten →